Literature DB >> 19960218

Acute subdural hemorrhage associated with rifampicin-induced thrombocytopenia.

Sa-Yoon Kang1, Jay Chol Choi, Ji-Hoon Kang, Jung Seok Lee.   

Abstract

Thrombocytopenia is a major adverse effect of several drug treatments. Rifampicin has been recognized as a cause of immune thrombocytopenia. A 68-year-old woman diagnosed with pulmonary tuberculosis was taking the standard four-drug antituberculosis regimen for 4 months. She presented with decreased responsiveness and headache. Brain MRI revealed subdural hemorrhage along the falx cerebri and high convexity. The platelet count was 8,000 microL(-1). Intracranial hemorrhage due to rifampicin-induced thrombocytopenia has not, to our knowledge, been previously reported. We report a patient with acute subdural hemorrhage associated with rifampicin-induced thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19960218     DOI: 10.1007/s10072-009-0187-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  6 in total

1.  Antibodies against rifampin in patients with tuberculosis after discontinuation of daily treatment.

Authors:  L Di Berardino; G Perna; L G Silvestri
Journal:  Am Rev Respir Dis       Date:  1976-12

2.  Rifampicin-dependent antibodies bind a similar or identical epitope to glycoprotein IX-specific quinine-dependent antibodies.

Authors:  J K Burgess; J A Lopez; L E Gaudry; B H Chong
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

3.  Rifampicin-induced immune thrombocytopenia.

Authors:  Y S Mehta; F F Jijina; S S Badakere; A V Pathare; D Mohanty
Journal:  Tuber Lung Dis       Date:  1996-12

4.  Sensitivity to rifampicin: incidence, mechanism, and prevention.

Authors:  J C Pujet; J C Homberg; G Decroix
Journal:  Br Med J       Date:  1974-05-25

Review 5.  Hypersensitivity reactions to rifampin. Pathogenetic mechanisms, clinical manifestations, management strategies, and review of the anaphylactic-like reactions.

Authors:  E Martínez; J Collazos; J Mayo
Journal:  Medicine (Baltimore)       Date:  1999-11       Impact factor: 1.889

6.  Glycoprotein Ib/IX complex is the target in rifampicin-induced immune thrombocytopenia.

Authors:  J Pereira; P Hidalgo; M Ocqueteau; M Blacutt; M Marchesse; Y Nien; L Letelier; D Mezzano
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

  6 in total
  2 in total

1.  Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

Authors:  Edeltraut Garbe; Frank Andersohn; Elisabeth Bronder; Abdulgabar Salama; Andreas Klimpel; Michael Thomae; Hubert Schrezenmeier; Martin Hildebrandt; Ernst Späth-Schwalbe; Andreas Grüneisen; Oliver Meyer; Hanife Kurtal
Journal:  Eur J Clin Pharmacol       Date:  2011-12-21       Impact factor: 2.953

2.  Genetic polymorphisms of long noncoding RNA RP11-37B2.1 associate with susceptibility of tuberculosis and adverse events of antituberculosis drugs in west China.

Authors:  Jiajia Song; Tangyuheng Liu; Zhenzhen Zhao; Xuejiao Hu; Qian Wu; Wu Peng; Xuerong Chen; Binwu Ying
Journal:  J Clin Lab Anal       Date:  2019-03-28       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.